“Are Strained Borders Eroding Innovation? 85% of Life Science Experts Fear AI Regulations Could Stifle Global Collaboration!”
In a world where artificial intelligence (AI) is increasingly becoming the backbone of research and development, it’s perplexing to see that some life science professionals still feel like they’re navigating a minefield when it comes to regulations—especially across borders. A recent global survey by The Pistoia Alliance in collaboration with the Copyright Clearance Center uncovered some startling insights: while an impressive 83% of respondents are harnessing the power of generative AI, a whopping 85% express concern about inconsistent AI regulations hampering their collaborative efforts. And let this sink in—42% of the professionals aren’t even considering copyright implications before employing third-party information with AI tools. It makes you wonder: in the race to innovate, are we overlooking the important legal frameworks that could safeguard our breakthroughs? Join the conversation as we delve into the implications of this survey and what it could mean for the future of pharma R&D. LEARN MORE
Survey: 85 percent of lifescience professionals concerned about impact of differing AI regulations on cross-border collaboration
Post Comment